心血管代谢性危险因素在过敏性及非过敏性哮喘中的研究现况

艾克 丹木, 努尔 阿米, 韩利 梅*
新疆医科大学第二附属医院 新疆乌鲁木齐 830000

摘要

摘要：支气管哮喘(bronchi alasthma，BA)是常见的慢性气道炎症性疾病，在成人呼吸系统疾病中较为常见，哮喘临床表现广泛，影响着全世界3亿多患者[1]。全球哮喘防治创议(GlobalInitiativeforAsthma，GINA)将支气管哮喘定义为一种异质性疾病，主要以反复发作的临床症状，如喘息、气短、胸闷和咳嗽、气流受限、气道高反应性及气道炎症反应为特征[2]，其常见表型为过敏性哮喘与非过敏性哮喘，二者间区别主要在于患者对变应原刺激的反应。然而，哮喘和CVD(Cardiovasculardisease，CVD)之间的关系越来越密切，共同特点是慢性全身炎症的持续存在，这最终导致控制不良的哮喘和动脉粥样硬化或缺血性心血管疾病[3]。了解哮喘和心血管风险因素之间的关联对于判断哮喘的病情、预后及治疗效果，能为临床上个体化地治疗哮喘提供重要依据。现就心血管代谢性危险因素在不同表型哮喘中的研究进展予以综述。

关键词

关键词：过敏性哮喘；非过敏性哮喘；心血管代谢性危险因素

参考

[1]TOPPILA-SALMI S, CHANOINE S, KARJALAINEN J, et al.Risk of adult-onset asthma increases with the number of allergicmultimorbidities and decreases with age [J]. Allergy, 2019, 74(12):2406-16.[2]REDDEL H K, BACHARIER L B, BATEMAN E D, et al. GlobalInitiative for Asthma Strategy 2021: executive summary and rationale forkey changes [J]. Eur Respir J, 2022, 59(1).[3]TATTERSALL M C, GUO M, KORCARZ C E, et al. Asthmapredicts cardiovascular disease events: the multi-ethnic study ofatherosclerosis [J]. Arterioscler Thromb Vasc Biol, 2015, 35(6): 1520-5.[4]SINGH S S, PILKERTON C S, SHRADER C D, et al. Subclinicalatherosclerosis, cardiovascular health, and disease risk: is there a case forthe Cardiovascular Health Index in the primary prevention population? [J].BMC Public Health, 2018, 18(1): 429.[5]CARTER P, LAGAN J, FORTUNE C, et al. Association ofCardiovascular Disease With Respiratory Disease [J]. J Am Coll Cardiol,2019, 73(17): 2166-77.[6]POLLEVICK M E, XU K Y, MHANGO G, et al. The RelationshipBetween Asthma and Cardiovascular Disease: An Examination of theFramingham Offspring Study [J]. Chest, 2021, 159(4): 1338-45.[7]焦莹莹, 王柳森, 王志宏, et al. 中国 15 省市 18～35 岁居民心血管代谢性危险因素分析 [J]. 营养学报, 2022, 44(03): 218-23.[8]WEE J H, PARK M W, MIN C, et al. Association between asthmaand cardiovascular disease [J]. Eur J Clin Invest, 2021, 51(3): e13396.[9]KATSIKI N, DOUMAS M. Emerging Cardiovascular Risk Factorsand Specific Patient Populations at Increased Cardiovascular Risk [J].Curr Vasc Pharmacol, 2021, 19(3): 241-2.[10]CAZZOLA M, ROGLIANI P, ORA J, et al. Asthma andcomorbidities: recent advances [J]. Pol Arch Intern Med, 2022, 132(4).[11]TAN L D. Further Insight Into the Intimate RelationshipBetween Asthma and Cardiovascular Disease [J]. Chest, 2021, 159(4):1311-2.[12]李建军. 心血管代谢相关危险因素是心血管疾病防控的关键 [J]. 中国循环杂志, 2022, 37(10): 969-73.[13]JIANG T, DAI L, LI P, et al. Lipid metabolism and identificationof biomarkers in asthma by lipidomic analysis [J]. Biochim Biophys ActaMol Cell Biol Lipids, 2021, 1866(2): 158853.[14]FORNO E, WEINER D J, MULLEN J, et al. Obesity and AirwayDysanapsis in Children with and without Asthma [J]. Am J Respir CritCare Med, 2017, 195(3): 314-23.[15]BANTULÀ M, ROCA-FERRER J, ARISMENDI E, et al.Asthma and Obesity: Two Diseases on the Rise and Bridged byInflammation [J]. J Clin Med, 2021, 10(2).[16]MIETHE S, KARSONOVA A, KARAULOV A, et al. Obesityand asthma [J]. J Allergy Clin Immunol, 2020, 146(4): 685-93.[17]LI W-J, ZHAO Y, GAO Y, et al. Lipid metabolism in asthma:Immune regulation and potential therapeutic target [J]. Cell Immunol,2021, 364: 104341.[18]BARROS R, MOREIRA P, PADRÃO P, et al. Obesity increasesthe prevalence and the incidence of asthma and worsens asthma severity[J]. Clin Nutr, 2017, 36(4): 1068-74.[19]ATHYROS V G, DOUMAS M, IMPRIALOS K P, et al. Diabetesand lipid metabolism [J]. Hormones (Athens), 2018, 17(1): 61-7.[20]梁引红, 师静梅. 2 型糖尿病患者心血管风险和血清胰高血糖素样肽-1 水平关系研究 [J]. 中国药物与临床, 2021, 21(16):2779-81.[21]WU T D. Diabetes and Glycemic Dysfunction in Asthma [J]. JAllergy Clin Immunol Pract, 2020, 8(10): 3416-7.[22]KATAKAMI N. Mechanism of Development of Atherosclerosisand Cardiovascular Disease in Diabetes Mellitus [J]. J AtherosclerThromb, 2018, 25(1): 27-39.[23]WU T D, BRIGHAM E P, KEET C A, et al. AssociationBetween Prediabetes/Diabetes and Asthma Exacerbations in aClaims-Based Obese Asthma Cohort [J]. J Allergy Clin Immunol Pract,2019, 7(6).[24]姜丽萍. 冠心病及代谢性心血管危险因素与动脉弹性相关性研究进展 [J]. 世界最新医学信息文摘, 2017, 17(75): 60.[25]郑秀琴, 黄江英. 高血压前期的流行病学特征及其与心血管疾病危险因素及多代谢异常的相关性分析 [J]. 包头医学院学报,2017, 33(08): 92-4.[26]LEE K H, LEE H S. Hypertension and diabetes mellitus as riskfactors for asthma in Korean adults: the Sixth Korea National Health andNutrition Examination Survey [J]. Int Health, 2020, 12(4): 246-52.[27]杜小燕. 高血压患者心血管病发病风险及多重危险因素的研究 [J]. 名医, 2022, (09): 21-3.[28]HAMILTON D, LEHMAN H. Asthma Phenotypes as a Guide forCurrent and Future Biologic Therapies [J]. Clin Rev Allergy Immunol,2020, 59(2): 160-74.[29]FINOTTO S. Resolution of allergic asthma [J]. SeminImmunopathol, 2019, 41(6): 665-74.[30]FERNÁNDEZ-GALLEGO N, CASTILLO-GONZÁLEZ R,MÉNDEZ-BARBERO N, et al. The impact of type 2 immunity andallergic diseases in atherosclerosis [J]. Allergy, 2022, 77(11): 3249-66.[31]TRAKAKI A, MARSCHE G. High-Density Lipoprotein (HDL)in Allergy and Skin Diseases: Focus on Immunomodulating Functions [J].Biomedicines, 2020, 8(12).[32]GAO S, WANG C, LI W, et al. Allergic asthma aggravatedatherosclerosis increases cholesterol biosynthesis and foam cell formationin apolipoprotein E-deficient mice [J]. Biochem Biophys Res Commun,2019, 519(4): 861-7.[33]NIETO-FONTARIGO J J, GONZÁLEZ-BARCALA F J,ANDRADE-BULOS L J, et al. iTRAQ-based proteomic analysis revealspotential serum biomarkers of allergic and nonallergic asthma [J]. Allergy,2020, 75(12): 3171-83.[34]RASTOGI D. Pediatric obesity-related asthma: A prototype ofpediatric severe non-T2 asthma [J]. Pediatr Pulmonol, 2020, 55(3):809-17.